We only have this paper's title and publication details.
Read it at the sourceEvaluates the efficacy of eculizumab therapy for autoimmune hemolytic anemia in sickle cell disease, indicating potential improvement in treatment outcomes.
No takes yet. Share an insight, caveat, or question.
Hautefeuille et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: